KoBioLabs, Inc

Equities

A348150

KR7348150004

Food Processing

End-of-day quote Korea S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
7,730 KRW +1.31% Intraday chart for KoBioLabs, Inc +2.79% -9.17%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
5,607,000 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-NOV-2022. CI
KoBioLabs, Inc announced that it has received KRW 10.000016 billion in funding from E-MART Inc. CI
KoBioLabs to Raise $8 Million via Stock Offering MT
KoBioLabs, Inc announced that it expects to receive KRW 10.000016 billion in funding from E-MART Inc. CI
KoBioLabs, Inc announced that it has received KRW 6.99999775 billion in funding from Stonebridge Ventures Inc., Industrial Bank of Korea, Investment Arm and other investors CI
KoBioLabs, Inc announced that it has received KRW 4.64999775 billion in funding CI
KoBioLabs, Inc announced that it expects to receive KRW 6.99999775 billion in funding from Stonebridge Ventures Inc., Industrial Bank of Korea, Investment Arm and other investors CI
KoBioLabs, Inc announced that it has received KRW 44.4498035 billion in funding from Jaedam Inc., Cornerstone Investment Partners Co., Ltd. and other investors CI
1,130,196 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-NOV-2021. CI
Kobiolabs Targets Over $28 Million Through Stock Offering MT
KoBioLabs, Inc announced that it expects to receive KRW 44.4498035 billion in funding from Jaedam Inc., Cornerstone Investment Partners Co., Ltd. and other investors CI
KoBioLabs, Inc(KOSDAQ:A348150) added to S&P Global BMI Index CI
213,600 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-MAY-2021. CI
840,158 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-FEB-2021. CI
845,970 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-JAN-2021. CI
2,525,978 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-DEC-2020. CI
KoBioLabs,Inc has completed an IPO in the amount of KRW 30 billion. CI
KoBioLabs,Inc has filed an IPO. CI
KoBioLabs, Inc announced that it has received KRW 4 billion in funding from CJ Cheiljedang Corporation CI
Chart KoBioLabs, Inc
More charts
KoBioLabs Inc is a Korea-based company mainly engaged in the development and sales of functional probiotics. The Company's products are sold under the names of Bioviom and Queens henna FOODOLOGY. The Company is also engaged in the development of new microbiome drugs. In addition, the Company engages in commissioned research. The Company sells its products in domestic and overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. A348150 Stock
  4. News KoBioLabs, Inc
  5. KoBioLabs to Raise $8 Million via Stock Offering